Inovio to start COVID-19 vaccine trial after getting Brazil regulator approval

(Reuters) – Inovio Pharmaceuticals Inc said on Thursday it received authorization from Brazil’s regulatory agency to conduct mid-to-late stage trial of its COVID-19 vaccine.

(Reporting by Mrinalika Roy in Bengaluru)